Estimated Average Glucose (eAG) From HbA1C
ورودیهای بالینی بیمار
حداقل ۳ — حداکثر ۲۰ • واحد: %
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Normal≤ 125
- Prediabetes126–153
- Diabetes - Good Control154–182
- Diabetes - Moderate Control183–239
The Estimated Average Glucose (eAG) From HbA1C calculates evaluating glycemic control, metabolic decompensation severity, and long-term endocrine risks. Key inputs include hba1c percent. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Estimates average glucose level from Hemoglobin A1C value using the linear relationship established by the A1c-Derived Average Glucose (ADAG) Study Group.
Clinical Indication
The Estimated Average Glucose (eAG) From HbA1C is indicated for bedside clinical practice to support Estimates average glucose level from Hemoglobin A1C value using the linear relationship established by the A1c-Derived Average Glucose (ADAG) Study Group.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.
Limitations & Contraindications
Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.
Clinical Pearls & Action Plan
Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management.
eAG (mg/dL) = (28.7 × HbA1c %) - 46.7. This linear relationship was established by the A1c-Derived Average Glucose (ADAG) Study Group with r²=0.84.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| hba1c_percent | float | Yes | Hemoglobin A1C value as a percentage(%) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≤ 125 | Normal | Normal glucose levels |
| 126–153 | Prediabetes | Prediabetic range |
| 154–182 | Diabetes - Good Control | Diabetic range with good control |
| 183–239 | Diabetes - Moderate Control | Diabetic range with moderate control |
| ≥ 240 | Diabetes - Poor Control | Diabetic range with poor control |
Evidence-Based References (EBM)
- Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-8. doi: 10.2337/dc08-0545.DOI: 10.2337/dc08-0545
- American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S73-S84. doi: 10.2337/dc21-S006.DOI: 10.2337/dc21-S006
- International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-34. doi: 10.2337/dc09-9033.DOI: 10.2337/dc09-9033
- Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care. 2002;25(2):275-8. doi: 10.2337/diacare.25.2.275.DOI: 10.2337/diacare.25.2.275